Pfizer Inc.
PFELast close · Oct 16, 202629.58+0.14 (+0.48%)
Market cap$168.6B
Between Apr 23, 2026 and Oct 15, 2026, Pfizer (PFE) insiders filed 39 Form 4 transactions: 2 sales worth $134,661.2 in total and 3 open-market purchases worth $3.0M. The largest seller was Damico Jennifer B., $83,261.2. 34 other filings were grants, exercises or gifts, which say nothing about buying or selling.
39
3
2
0
Form 4 transactions
| Date | Insider | Title | Code | Plan | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | BOURLA ALBERT | Chairman & CEO | A | 20 | 29.44 | $588.8 | |
| 2026-10-13 | BOURLA ALBERT | Chairman & CEO | A | 71 | 28.37 | $2,014.3 | |
| 2026-09-30 | BOURLA ALBERT | Chairman & CEO | A | 21 | 28.52 | $598.9 | |
| 2026-09-25 | Buckley Mortimer J | Director | A | 1,308 | 28.67 | $37,500 | |
| 2026-09-25 | Echevarria Joseph | Director | A | 1,613 | 28.67 | $46,250 | |
| 2026-09-25 | NARAYEN SHANTANU | Director | A | 1,744 | 28.67 | $50,000 | |
| 2026-09-25 | Quincey James | Director | A | 1,352 | 28.67 | $38,750 | |
| 2026-09-25 | SMITH JAMES C | Director | A | 1,570 | 28.67 | $45,000 | |
| 2026-09-25 | Taraporevala Cyrus | Director | A | 1,308 | 28.67 | $37,500 | |
| 2026-09-15 | BOURLA ALBERT | Chairman & CEO | A | 22 | 27.55 | $606.1 | |
| 2026-08-31 | BOURLA ALBERT | Chairman & CEO | A | 21 | 28.46 | $597.7 | |
| 2026-08-14 | BOURLA ALBERT | Chairman & CEO | A | 22 | 26.79 | $589.4 | |
| 2026-08-12 | BOURLA ALBERT | Chairman & CEO | P | 38,000 | 26.34 | $1.0M | |
| 2026-08-05 | DAMICO JENNIFER B. | SVP & Controller | S | 3,278 | 25.40 | $83,261.2 | |
| 2026-08-05 | BLAYLOCK RONALD E | Director | P | 39,231 | 25.46 | $998,821.3 | |
| 2026-08-05 | Buckley Mortimer J | Director | P | 37,632 | 25.52 | $960,368.6 | |
| 2026-07-31 | BOURLA ALBERT | Chairman & CEO | A | 24 | 25.01 | $600.2 | |
| 2026-07-15 | BOURLA ALBERT | Chairman & CEO | A | 24 | 24.82 | $595.7 | |
| 2026-07-09 | BOURLA ALBERT | Chairman & CEO | A | 84 | 24.25 | $2,037 | |
| 2026-06-30 | BOURLA ALBERT | Chairman & CEO | A | 25 | 24.08 | $602 | |
| 2026-06-26 | Buckley Mortimer J | Director | A | 1,544 | 24.29 | $37,500 | |
| 2026-06-26 | Echevarria Joseph | Director | A | 1,904 | 24.29 | $46,250 | |
| 2026-06-26 | NARAYEN SHANTANU | Director | A | 2,058 | 24.29 | $50,000 | |
| 2026-06-26 | SMITH JAMES C | Director | A | 1,853 | 24.29 | $45,000 | |
| 2026-06-26 | Quincey James | Director | A | 1,595 | 24.29 | $38,750 | |
| 2026-06-26 | Taraporevala Cyrus | Director | A | 1,544 | 24.29 | $37,500 | |
| 2026-06-15 | BOURLA ALBERT | Chairman & CEO | A | 23 | 26.00 | $598 | |
| 2026-06-09 | DAMICO JENNIFER B. | SVP & Controller | S | 2,000 | 25.70 | $51,400 | |
| 2026-05-29 | BOURLA ALBERT | Chairman & CEO | A | 23 | 26.18 | $602.1 | |
| 2026-05-15 | BOURLA ALBERT | Chairman & CEO | A | 24 | 25.33 | $607.9 | |
| 2026-04-30 | BOURLA ALBERT | Chairman & CEO | A | 22 | 26.70 | $587.4 | |
| 2026-04-23 | Gottlieb Scott | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | NORA JOHNSON SUZANNE M | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | LITTMAN DAN R. | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | BLAYLOCK RONALD E | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | Buckley Mortimer J | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | Desmond-Hellmann Susan | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | Echevarria Joseph | Director | A | 7,687 | 26.67 | $205,000 | |
| 2026-04-23 | NARAYEN SHANTANU | Director | A | 7,687 | 26.67 | $205,000 |
Codes are the SEC's: P open-market purchase, S open-market sale; M exercise, F tax withholding, A grant and G gift are routine. A 10b5-1 flag means the trade ran under a plan adopted in advance. Method notes in where the numbers come from.